Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Westwood Holdings Group Inc.

Key Points

• Westwood Holdings Group Inc. increased its stake in Prestige Consumer Healthcare by 7.1%, now owning approximately 1.74% of the company, valued at around $74 million.
• Prestige Consumer Healthcare's recent quarterly earnings exceeded expectations, reporting an EPS of $1.32 versus a $1.30 consensus, with annual revenue growth of 7% to $296.52 million.
• Analysts have a consensus rating of "Moderate Buy" for Prestige Consumer Healthcare, with an average target price of $93.33 after several upgrades from major financial institutions.

Westwood Holdings Group Inc. grew its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 7.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 861,282 shares of the company's stock after purchasing an additional 56,802 shares during the period. Westwood Holdings Group Inc. owned 1.74% of Prestige Consumer Healthcare worth $74,044,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. CIBC Private Wealth Group LLC lifted its holdings in shares of Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after acquiring an additional 152 shares during the period. Opal Wealth Advisors LLC purchased a new position in shares of Prestige Consumer Healthcare during the 1st quarter worth about $38,000. Headlands Technologies LLC purchased a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth about $40,000. McIlrath & Eck LLC lifted its holdings in shares of Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after acquiring an additional 154 shares during the period. Finally, Johnson Financial Group Inc. purchased a new position in shares of Prestige Consumer Healthcare during the 4th quarter worth about $93,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Down 3.0%

NYSE PBH traded down $2.00 during mid-day trading on Friday, hitting $65.61. The company's stock had a trading volume of 785,601 shares, compared to its average volume of 440,546. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.82. Prestige Consumer Healthcare Inc. has a 52-week low of $63.78 and a 52-week high of $90.04. The stock's fifty day simple moving average is $79.26 and its two-hundred day simple moving average is $82.02. The firm has a market capitalization of $3.24 billion, a P/E ratio of 15.40, a price-to-earnings-growth ratio of 2.03 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. During the same period last year, the business earned $0.90 EPS. The firm's revenue was down 6.6% compared to the same quarter last year. Research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Wall Street Analyst Weigh In

PBH has been the topic of several recent analyst reports. Canaccord Genuity Group cut their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Finally, Wall Street Zen lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.